Progressive myopia

The inventor of the Eyerising International repeated low-level red light (RLRL) therapy for myopia, Professor Mingguang He, has outlined “notable...

At the completion of this article, the reader should be able to improve their knowledge of emerging myopia control interventions,...

EssilorLuxottica has unveiled new six-year clinical data at the 2025 China Optometry & Ophthalmology Conference (COOC), reinforcing the long-term efficacy...

Sydney optometrist DR OLIVER WOO explains why colleagues need to be on the look out for pre-myopes and how prescribing...

He’s only just had the upgrade installed but already this optometry practice owner is seeing the need for others to...

At the completion of this article, the reader should be able to discuss RLRL with their myopia patients,  including: Understand...

Repeated low-level red-light (RLRL) device manufacturer Eyerising International says the reclassification of the emerging myopia management intervention in China is...

At the completion of this article, the reader should be able to improve their myopia management approach, including... Recognise the...

Australian eyecare professionals are confident in the nation’s ability to combat the global myopia epidemic. Equipped with industry-leading products, a...

Tokyo Medical and Dental University (TMDU) will introduce the Eyerising Myopia Management Device for its myopia patients as part of...